ZK-002

N/A

Report date: 2022/06/28 17:58:05

Base Information

Drug NameZK-002
Drug Alias NameZK-002
ClassificationBiologics
Mechanisms of ActionAngiogenesis inhibitorsVascular endothelial growth factor receptor antagonists
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsDiabetic macular oedemaPterygium
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhaoke (Guangzhou) Ophthalmology Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhaoke (Guangzhou) Ophthalmology Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedemaPterygium
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A